Portolan Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-131,901	Closed	-$3.77M	–	144
2024 Q2	$3.77M	Buy	+131,901	New	+$3.77M	0.31%	99
2023 Q3	–	Sell	-200,504	Closed	-$8.03M	–	139
2023 Q2	$8.03M	Buy	+200,504	New	+$8.03M	0.71%	40